Adding clopidogrel does not reduce the risk of recurrent stroke in patients with a recent lacunar stroke who were taking aspirin, a subanalysis of a randomized, controlled clinical trial found.

In the past, cardiologists and neurologists tended to vote along party lines in the debate over closure devices vs. medical management of patients with a patent foramen ovale (PFO).

The Icahn School of Medicine at Mount Sinai joins a top-flight network of 25 regional stroke centers announced by the National Institute of Health that will focus on prevention, treatment, and recovery from stroke. As part of the NIH Stroke Trials Network (NIHStrokeNet), the medical school will receive a 5-year, $1.3 million grant to build a collaborative research infrastructure for a regional coordinating stroke center.

People who develop shingles between the ages of 18 and 40 may be at increased risk for a stroke, MI or a transient ischemia attack in later years, a study published online Jan. 2 in Neurology found.

Abbott Laboratories agreed to pay more than $5 million in a settlement over an alleged kickback scheme involving its carotid, biliary and peripheral vascular products.

Patients with atrial fibrillation who initiate warfarin therapy may have a two-fold risk of ischemic stroke in the first 30 days of use compared with nonusers, according to a study published online Dec. 18 in the European Heart Journal.

The University of Texas Health Science Center at Houston (UTHealth) has been named one of 25 regional stroke centers by the National Institutes of Health (NIH) and the only one in Texas.

Patients with stable hypertension and advanced chronic kidney disease who take medications that block the renin-angiotensin-aldosterone system may be less likely to need long-term dialysis than similar patients not treated with these drugs. Their risk of death also may be lower, according to study published online Dec. 16 in JAMA Internal Medicine.